Company Profiles

driven by the PitchBook Platform

Ikonisys

Description

Developer of diagnostic tests designed to transform diagnostic medicine through early, accurate and non-invasive disease detection. The company's diagnostic tests detect a single cell and identify its molecular signals, enabling large and regional reference labs, hospitals, research institutions and practice groups to reduce the risk of human error, lower costs, and expand test volume capacity.

1999

Founded

PRIVATE

Status

51-200

Employees

Later Stage VC

Latest Deal Type

$1.44M

Latest Deal Amount

$48.4M

Total Amount Raised

Description

Developer of diagnostic tests designed to transform diagnostic medicine through early, accurate and non-invasive disease detection. The company's diagnostic tests detect a single cell and identify its molecular signals, enabling large and regional reference labs, hospitals, research institutions and practice groups to reduce the risk of human error, lower costs, and expand test volume capacity.

Website:

www.ikonisys.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Other Devices and Supplies

Primary Office

5 Science Park New Haven, CT 06511United States +1 (203) 776-0791
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Ikonisys's full profile, request a free trial.

    Ikonisys Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Ikonisys Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Ikonisys Investors (14)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BioVisionVC-Backed CompanyMinority000 0000000 0000
    Connecticut InnovationsVenture CapitalMinority000 0000000 0000
    Deutsche BankInvestment BankMinority000 0000000 0000
    EverfinCorporationMinority000 0000000 0000
    Goldman Sachs Merchant Banking DivisionMerchant Banking FirmMinority000 0000000 0000
    BioVision VC-Backed Company
    Connecticut Innovations Venture Capital
    Deutsche Bank Investment Bank
    Everfin Corporation
    Goldman Sachs Merchant Banking Division Merchant Banking Firm

    Ikonisys Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Carlo MediciChief Executive Officer
    Triantafyllos Tafas Ph.DPresident, Co-founder & Board Member
    Mary MansfieldController
    Eric KershnarDirector, Business Development
    Maribeth StewartDirector of Operations, Clinical Laboratory, Quality Assurance and Regulatory Compliance
    Carlo Medici Chief Executive Officer
    Triantafyllos Tafas Ph.D President, Co-founder & Board Member
    Mary Mansfield Controller
    Eric Kershnar Director, Business Development
    Maribeth Stewart Director of Operations, Clinical Laboratory, Quality Assurance and Regulatory Compliance

    Ikonisys Board Members (10)

    NameRepresentingRoleSinceContact
    Info
    Andrew Fink JDTrevi Health VenturesCo-Founder & Managing Director000 0000
    Christopher DaweSelfBoard Member000 0000
    Fulvio BraccoSelfBoard Member000 0000
    Marco PreteSelfBoard Member000 0000
    Mario MauriSelfBoard Member000 0000
    Andrew Fink JD Co-Founder & Managing Director Trevi Health Ventures
    Christopher Dawe Board Member Self
    Fulvio Bracco Board Member Self
    Marco Prete Board Member Self
    Mario Mauri Board Member Self
    Request full access to PitchBook